NCT06334172 The Role of Oxytocin in Regulating Blood Glucose
| NCT ID | NCT06334172 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Gentofte, Copenhagen |
| Condition | Glucose Metabolism Disorders (Including Diabetes Mellitus) |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Investigating the effect of oxytocin on pancreatic endocrine functions by determining insulin and glucagon secretion within physiological ranges of plasma glucose.
Eligibility Criteria
Inclusion Criteria: * BMI 19-25 kg/m2 Exclusion Criteria: * Diabetes * Heart-, liver or kidney disease * More than 14 units of alcohol weekly, or drug abuse * Smoking or any kind of nicotine products * Alanin aminotransferase (ALAT) ≥ 2 × normal range * Estimated glomerular filtration rate (eGFR) \< 60 ml/min/1,73m2 or creatinine above normal range * Blood pressure \> 140/90 * Hemoglobin \< normal range * Corrected QT Interval (Qtc) \>0,45 sec. at electrocardiogram (ECG) at screening * Known disease in the pituitary gland or previous pituitary surgery * Any other disease/condition which the trial managers believe may affect participation in the trial
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06334172 clinical trial?
This trial is open to male participants only, aged 20 Years or older, up to 50 Years, studying Glucose Metabolism Disorders (Including Diabetes Mellitus). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06334172 currently recruiting?
Yes, NCT06334172 is actively recruiting participants. Contact the research team at vivian.kliim-hansen@regionh.dk for enrollment information.
Where is the NCT06334172 trial being conducted?
This trial is being conducted at Hellerup, Denmark.
Who is sponsoring the NCT06334172 clinical trial?
NCT06334172 is sponsored by University Hospital, Gentofte, Copenhagen. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.